Bo Cum­bo jumps from the top com­mer­cial post at Sarep­ta to the helm of a gene ther­a­py start­up with some in­flu­en­tial back­ers, big plans and $107M

Af­ter a 7-year stretch build­ing the com­mer­cial team at Sarep­ta, long­time drug sales­man Bo Cum­bo is jump­ing to the en­tre­pre­neur­ial side of the busi­ness, tak­ing the helm of a start­up that’s got sev­er­al deep-pock­et in­vestors. And he’s not just bring­ing his ex­pe­ri­ence in sell­ing drugs.

He tells me that when he told Sarep­ta CEO Doug In­gram about it, his boss got ex­cit­ed about the ven­ture and opt­ed to jump in with a $15 mil­lion in­vest­ment from Sarep­ta to add to the launch mon­ey, along­side 3 of the busiest in­vestors in biotech.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER